新型生物连接的两性[4]以为基础的超分子体作为多克索鲁比辛载体,增强抗癌活性
Dan Du1,2, Yu-Dun Liu1,2, Jun-Bing Lan1,2
1College of Pharmacy, Xuzhou Medical University, Xuzhou 221004, P. R. China.
概括
新型生物素连接[4]arenes 创建一个 doxorubicin 纳米复合物用于向药物输送. 这种BPCA4-DOX复合体在临床前研究中显示出增强的抗瘤活性和减少副作用.
科学领域:
- 超分子化学 超分子化学
- 纳米技术纳米技术
- 在瘤学瘤学.
背景情况:
- 超分子载体在化疗中提供有针对性的药物递送潜力.
- 卡利沙伦是分子复杂化的多功能宏循环宿主.
研究的目的:
- 设计和合成用于药物输送的新型生物连接[4]场.
- 为了评估 doxorubicin 纳米复合物的抗瘤疗效和安全性.
主要方法:
- 合成四种与生物相关的[4]衍生物 (BPCA1-BPCA4).
- 纳米复合物的形成与多克索鲁比 (DOX).
- 在体外和体外的抗瘤活性和副作用评估.
主要成果:
- BPCA4-DOX纳米复合体表现出极好的稳定性.
- 对BPCA4-DOX.观察到明显优异的抗瘤活性.
- 与对照组相比,人们注意到副作用的减少.
结论:
- 生物素连接的[4]是多克索鲁比的有效的超分子载体.
- BPCA4-DOX纳米复合体代表了增强癌症化疗的有希望的战略.
- 需要对临床应用进行进一步的研究.
相关概念视频
Drugs that Stabilize Microtubules
2.1K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
Drugs that Destabilize Microtubules
2.0K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.0K


